SHOP vs SLRX · P/E 107, rev $3.58B vs $4.9M cap
Shopify Inc (SHOP) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
Shopify Inc (SHOP) is a software - application company listed on US. It is led by Tobi Lutke.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported SHOP revenue for 2026-06-30 was $3.58B. Net income was $1.50B. Revenue was up 13.0% from 2026-03-31 to 2026-06-30. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
SHOP currently screens at market cap $142.15B and trailing P/E 107.4. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the SHOP and SLRX stock pages for the full models.
Not investment advice.